Replies to post #69467 on Biotech Values

[DewDiligence]

>Couldn't this constitute another approved generic in the context of lowering MNTA’s royalty rate? Or would the sole approved generic designation apply to each of the specific product formulations?<

The latter. Technically, the Sandoz-MNTA Lovenox collaboration consists of two products: the vial and the syringe. Each of these has its own ANDA.